| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Bioatla, Inc. (BCAB) has 4 insiders with recent SEC Form 4 filings, including 3 buys and 12 sells. BCAB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.66M | $9.72M | - | |
| Other | 598.7K | $2.19M | - | |
| CFO | 530.2K | $1.94M | - | |
| CFO | 343.4K | $1.26M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2021 | Levy Guy | Director | Sell | 400,000 | $39.16 | $15,664,000.00 | -18.8% | -4.0% | -93.2% | |
| Jun 16, 2021 | Short Jay M Phd87 | Chief Executive Officer | Sell | 146,137 | $40.06 | $5,854,430.22 | -1.6% | -4.9% | -93.7% | |
| Dec 18, 2020 | Cormorant Asset Management, LP49 | Former 10% Owner | Buy | 800,000 | $18.00 | $14,400,000.00 | +53.6% | - | - | |
| Dec 18, 2020 | Levy Guy | Director | Buy | 1,388,890 | $18.00 | $25,000,020.00 | New | - | - |